BDX Stock Summary and Trading Ideas (Becton Dickinson And Company | NYSE:BDX)

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.

As of April 29, 2026, BDX stock price declined to $145.31 with 2,812,561 million shares trading.

BDX has a beta of 0.51, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.05 to the broad based SPY ETF.

BDX has a market cap of $41.34 billion. This is considered a Large Cap stock.

Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $2.91 earnings per share. This beat revenue expectation by $104 million and exceeded earnings estimates by $.09.

In the last 3 years, BDX traded as high as $287.32 and as low as $144.51.

The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

BDX has underperformed the market in the last year with a price return of -5.2% while the SPY ETF gained +30.5%. BDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.5% and -6.7%, respectively, while the SPY returned +2.6% and +2.5%, respectively.

BDX support price is $147.53 and resistance is $151.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX shares will trade within this expected range on the day.